Mediclinic completes R5bn rights issue
Mediclinic’s R5bn ($568m) rights issue was 99.7% subscribed, the company said on Monday. The South African private healthcare company, which is listed on the Johannesburg Stock Exchange, will use proceeds from the deal to support a R28bn loan refinancing.
The offer closed on Friday, and new shares were issued on Monday. The remaining 0.3% of the offer, 475,093 shares, will be allocated to shareholders who applied for excess shares.
Mediclinic offered a total of 174.6m shares. Shareholders could buy 26.77 shares at R28.63 each for every 100 held.
To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: email@example.com or find out more online here.